Navigation Links
Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome
Date:1/15/2014

ed by an additional four weeks of open label treatment, the results of which are not yet available.  The trial enrolled 17 patients with genetically confirmed PWS, including 11 women and 6 men, with a mean age of 33.9 years, and mean body mass index (BMI) of 31.4 kg/m2.  Beloranib appeared to be safe and very well-tolerated.  All 17 patients completed the randomized treatment part of the trial and all opted to continue into and completed the four-week open label extension.

About Prader-Willi Syndrome
Prader-Willi syndrome (PWS), the most common known genetic cause of life-threatening obesity, causes constant hunger that drives PWS patients to gain more weight on fewer calories than the average person.  As a result, many of those affected become morbidly obese before the age of five.  There is currently no cure for this disease.  Although the cause is complex, it results from a deletion or loss of function of a cluster of genes on the 15th chromosome.  PWS typically causes low muscle mass and function, short stature, incomplete sexual development, and a chronic feeling of hunger that, coupled with a metabolism that utilizes drastically fewer calories than normal, can lead to excessive eating and life-threatening obesity.  PWS occurs in males and females equally and in all races, with the same incidence around the world.  Prevalence estimates have ranged from 1:8,000 to 1:50,000 with the most likely figure being approximately 1:40,000.  To the best of our knowledge, prevalence is about 5,000-7,000 people in the United States needing treatment.  You can learn more through the Prader-Willi Syndrome Association website at www.pwsausa.org.

About Beloranib
Beloranib is the first compound in its class that works by targeting a key enzyme called MetAP2 that controls the production and utilization of fatty acids.  Inh
'/>"/>

SOURCE Zafgen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Zafgen Announces Initiation of Phase 2a Clinical Development with Beloranib in Obesity
2. Zafgen Secures $21 Million in Series D Financing
3. Zafgen Announces New Weight Loss and Safety Data from Phase 2 Study of Beloranib in Obesity at Obesity Week 2013
4. Zafgen Secures $45 Million in Series E Financing
5. Zafgen Appoints Chief Commercial Officer and New Member of Board of Directors
6. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... DALLAS , September 2, 2014 ... Chromatography Column Market by Type (Empty, Pre-packed, Analytical, Preparative), by Material ... Flash Chromatography, UFLC), TLC,SFC] - Forecast to 2018", published by ... Million in 2013. It is poised to grow at ... Million by 2018. Browse 90 market ...
(Date:9/2/2014)... 2014 Particle Sciences, the leading CDMO for ... development and manufacturing capabilities with the addition of a ... Particle Sciences, Associate Director Clinical Production, "The company has ... square footage, equipment and staff across the board, all ... has over 6000ft 2 of operating cleanroom and ...
(Date:9/2/2014)... , Sept. 2, 2014 /PRNewswire-iReach/ -- Ortho Development® ... Alpine™ Hip Stem, the latest addition to its ... Stem is intended for use in total hip ... http://photos.prnewswire.com/prnh/20140830/141676 Alpine was ... stem philosophy. ODEV,s engineers worked closely with a ...
Breaking Medicine Technology:Chiral Chromatography Column Market Worth $87.8 Million by 2018 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 3Chiral Chromatography Column Market Worth $87.8 Million by 2018 4Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources 2Ortho Development Receives FDA Clearance for Alpine Hip Stem 2
... 15 VION,PHARMACEUTICALS, INC. (Nasdaq: VION ) today ... to the pivotal Phase II trial of its lead ... novo poor-risk acute myelogenous leukemia (AML). Alan Kessman, ... reached this milestone in the pivotal Phase II trial ...
... Study to Explore the Efficacy of Novel Proteasome Inhibitor ... Patients with Relapsed and Refractory Multiple Myeloma, SOUTH ... Multiple Myeloma Research Consortium (MMRC) and Proteolix, Inc. today,announced ... Phase 2,clinical trial to study Proteolix,s potent and selective ...
Cached Medicine Technology:Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 2Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 3Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 4The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 2The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 3The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 4
(Date:9/2/2014)... Illinois (PRWEB) September 02, 2014 ... Chief Executive Officer and Chief Information Officer Strategy ... Carlton Chicago. , Becker's Hospital Review Chief Executive ... together hospital and health system Chief Executive Officers, ... hospital and health system executives through high-quality ...
(Date:9/2/2014)... FL (PRWEB) September 02, 2014 After respective performances ... compete against each other on September 5th at Sun Life Stadium. ... the brightest stars in the world of football in Colombian and ... some of the best talent in the world in early September. ... the world according to FIFA. The host nation of the ...
(Date:9/2/2014)... (PRWEB) September 03, 2014 Recently, iFitDress.com, ... special occasion gowns, has released its range of 2014 ... are now offered at low prices. A large proportion ... the beautiful products from iFitDress.com are carefully made by ... it also offers bachelorette party gowns, ivory satin wedding ...
(Date:9/2/2014)... BOSTON (September 2, 2014 4 pm EDT): In a ... American Medical Association , a team of Boston researchers ... improve dietary quality in the United States. The researchers ... at Tufts University, Harvard University and Boston Children,s Hospital ... subsidizing healthier foods could both help people make meaningful ...
(Date:9/2/2014)... 2014 The exciting information sessions and ... Carey Lewis and Bob Wiley. The team ... who have the desire to illuminate entertainment with the ... could be invited to join the Bridge Training ... – Saturday, Sept. 6, Charlotte Convention Center, 501 South ...
Breaking Medicine News(10 mins):Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 2Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 3Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 4Health News:Brazil Vs. Colombia Tickets in Miami at Sun Life Stadium: Dazzling Deals Tickets Advises Soccer Fans To Reserve Tickets Early for Brazil vs. Colombia Rematch in Florida 2Health News:Brazil Vs. Colombia Tickets in Miami at Sun Life Stadium: Dazzling Deals Tickets Advises Soccer Fans To Reserve Tickets Early for Brazil vs. Colombia Rematch in Florida 3Health News:Discounted Seashell Wedding Dresses Currently Provided By iFitDress.com 2Health News:Taxes and subsidies could encourage healthier diet and lower healthcare costs 2Health News:Actors, Models and Talent for Christ Auditions Are Set for Charlotte and Omaha on Saturday, September 6, 2014 2
... , NORTH DARTMOUTH, Mass., Sept. 10 The ... is now offering all sleep medicine services at one location. ... the 84 Faunce Corner Road location in North Dartmouth, MA, ... their sleep disorders. , , While at ...
... , BALTIMORE, Sept. 10 The following statement ... Addiction Treatment Gap (CATG) initiative: , , ... addiction remains at pandemic levels, with 23 million Americans suffering from ... diabetes. But you wouldn,t know it from the way our ...
... , FORT LAUDERDALE, Fla., Sept. 10 ... on the dangers of synthetic hormone replacement therapy for menopausal women, ... safer treatment option. , , A white ... , published in the October edition of Life Extension ...
... NEW YORK, Sept. 10 Reportlinker.com announces that a new ... , North America Air Purification Equipment ... http://www.reportlinker.com/p0109900/North-America-Air-Purification-Equipment-Market.html , , ... Equipment in US$ Million & Thousand Units The market is ...
... SXC Health Solutions Corp. ("SXC" or the "Company") (NASDAQ: ... of technology and pharmacy benefit management (PBM) services, announced ... to June 30, 2011, for its informedRx PBM business ... Hawaii. Under the agreement, SXC is providing full-service PBM ...
... Sept. 10 Reportlinker.com announces that a new market research ... World Botulinum Toxin Market , ... This report analyzes the worldwide markets for Botulinum ... for ,Botulinum Toxin, by the Following Segments: Cosmetic, and Therapeutic ...
Cached Medicine News:Health News:Sleep HealthCenters and Southcoast Hospitals Group Expand Patient Services in North Dartmouth 2Health News:Closing the Addiction Treatment Gap (CATG) Statement on Annual National Survey on Drug Use and Health Data Released by the Substance Abuse and Mental Health Services Administration (SAMHSA) 2Health News:Closing the Addiction Treatment Gap (CATG) Statement on Annual National Survey on Drug Use and Health Data Released by the Substance Abuse and Mental Health Services Administration (SAMHSA) 3Health News:The End of the Bio-Identical Hormone Debate 2Health News:Reportlinker Adds North America Air Purification Equipment Market Report 2Health News:Reportlinker Adds North America Air Purification Equipment Market Report 3Health News:Reportlinker Adds North America Air Purification Equipment Market Report 4Health News:Reportlinker Adds North America Air Purification Equipment Market Report 5Health News:Reportlinker Adds North America Air Purification Equipment Market Report 6Health News:Reportlinker Adds North America Air Purification Equipment Market Report 7Health News:Reportlinker Adds North America Air Purification Equipment Market Report 8Health News:Reportlinker Adds North America Air Purification Equipment Market Report 9Health News:Reportlinker Adds North America Air Purification Equipment Market Report 10Health News:Reportlinker Adds North America Air Purification Equipment Market Report 11Health News:Reportlinker Adds North America Air Purification Equipment Market Report 12Health News:Reportlinker Adds North America Air Purification Equipment Market Report 13Health News:Reportlinker Adds North America Air Purification Equipment Market Report 14Health News:Reportlinker Adds North America Air Purification Equipment Market Report 15Health News:SXC Health Solutions announces PBM contract renewal with Hawaii Employer-Union Health Benefits Trust Fund 2Health News:SXC Health Solutions announces PBM contract renewal with Hawaii Employer-Union Health Benefits Trust Fund 3Health News:SXC Health Solutions announces PBM contract renewal with Hawaii Employer-Union Health Benefits Trust Fund 4Health News:Reportlinker Adds World Botulinum Toxin Market Report 2Health News:Reportlinker Adds World Botulinum Toxin Market Report 3Health News:Reportlinker Adds World Botulinum Toxin Market Report 4Health News:Reportlinker Adds World Botulinum Toxin Market Report 5Health News:Reportlinker Adds World Botulinum Toxin Market Report 6Health News:Reportlinker Adds World Botulinum Toxin Market Report 7Health News:Reportlinker Adds World Botulinum Toxin Market Report 8Health News:Reportlinker Adds World Botulinum Toxin Market Report 9Health News:Reportlinker Adds World Botulinum Toxin Market Report 10Health News:Reportlinker Adds World Botulinum Toxin Market Report 11Health News:Reportlinker Adds World Botulinum Toxin Market Report 12
... Lyra-i system combines the longest available wavelength ... maximize patient safety and efficacy. The unique ... the therapeutic range to all targeted structures. ... ensuring patient safety. All Lyra-I patients are ...
... The Company's Aura-i Laser System is ... designed for office-based procedures. Its unique, integrated ... benign vascular, including telangiectasia on the leg ... leg veins. It can also be used ...
Surgisis Inguinal Hernia Matrix is implanted to reinforce soft tissues in the inguinal floor to repair inguinal hernias. Supplied sterile in peel-open packages. Intended for one-time use....
Used for implantation to reinforce soft tissue in the repair of a hernia or body wall defect. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: